Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Roberta RamondaMariagrazia LorenzinAntonio CarrieroMaria Sole ChimentiRaffaele ScarpaAntonio MarchesoniEnnio Lubrano di ScorpanielloCarlo SalvaraniAlberto CauliAngelo SemeraroLeonardo SantoAugusta OrtolanAndrea DoriaElena FracassiGiulia VirelliMarco MasiaRosalinda FanizziElisa VisalliGiorgio AmatoAntonio CarlettoRosario Fotinull nullPublished in: RMD open (2021)
In a real-life clinical setting, secukimumab proved safe and effective in all PsA domains, with notable drug retention rate.